Discover how Sanofi, a global pharmaceutical company, is shaping healthcare in the US with innovative solutions and treatments.
At Sanofi, we’re proud to be premium partner of Paris 2024. Like Olympians and Paralympians, we spend every day challenging ourselves and each other to be better, go further, and to never, ever settle as we chase the miracles of science to improve people’s lives. ...
Sanofi pushes scientific boundaries to develop breakthrough medicines and vaccines. We chase the miracles of science to improve people’s lives.
赛诺菲集团(Sanofi)周一表示,该公司研发的肾上腺素注射液Auvi-Q已获FDA批准用于易发过敏或有过敏史人群发生致命性过敏反应时 …yao.dxy.cn|基于144个网页 3. 法国赛诺菲 在法国赛诺菲(Sanofi),美国礼来(Eli Lilly),英国GSK公司工作17年,从销售代表成长为市场销售总监 毕业于华西医科大学,并拥有美 …class.admin5....
Press Release: Nirsevimab: Sanofi, AstraZeneca and Sobi simplify contractual agreements April 10, 2023 Press releases Press Release: Sanofi announces withdrawal and refiling of Premerger Notification and Report Form under the HSR Act and extension of tender offer to acquire Provention Bio, Inc. ...
Sanofi pushes scientific boundaries to develop breakthrough medicines and vaccines. We chase the miracles of science to improve people’s lives.
药融圈获悉:近期,法国跨国制药巨头赛诺菲(Sanofi)正在与美国私募股权投资机构Clayton,Dubilier&Rice(CD&R)进行谈判,或将出售旗下消费者健康业务部门Opella的50%控股权。 9月底,外媒报道,赛诺菲收到 PAI Partners 和 CD&R对Opella的单独报价,估值可能达155亿欧元(约169亿美元)。目前Opella在全球拥有11000名员工,13个生产...
▼ 90.05% 道琼斯 标准普尔 港汇 7.7850 0.0063% ▼ 登入 注册 详细报价 最近查詢 图表分析 互动图表 同业 新闻 派息 公司资料 (SNY.US) (美元) 升跌 成交量 买价(延迟) 前收市价/开市 / 升跌(%) 市值 卖价(延迟) 波幅 市盈率(倍)1 /TTM2 ...
At Sanofi, our rewards are strongly connected to business achievement, team success and individual performance. Every employee has the opportunity to exchange with their manager, agree to annual performance and development goals, and determine how they can be accomplished. These are typically reviewed...
Discover Sanofi’s commitment to advancing healthcare through innovative medicines across various specialty and general medicine focus areas.